Tonix Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800.

CEO

Seth Lederman

CEOSeth Lederman

Employees

Employees81

Headquarters

Chatham, New Jersey

HeadquartersChatham, New Jersey

Founded

2007

Founded2007

Employees

Employees81

TNXP Key Statistics

Market cap

242.55M

Market cap242.55M

Price-Earnings ratio

-0.03

Price-Earnings ratio-0.03

Dividend yield

—

Dividend yield—

Average volume

1.30M

Average volume1.30M

High today

$29.19

High today$29.19

Low today

$26.89

Low today$26.89

Open price

$27.01

Open price$27.01

Volume

1.46M

Volume1.46M

52 Week high

$130.00

52 Week high$130.00

52 Week low

$6.76

52 Week low$6.76

TNXP News

Seeking Alpha 16h

Tonix Pharmaceuticals gets global rights to Lyme disease treatment

Healthcare Tonix Pharmaceuticals gets global rights to Lyme disease treatment Sep. 17, 2025 12:38 PM ET Tonix Pharmaceuticals Holding Corp. (TNXP) Stock By: Nil...

TipRanks 22h

Tonix Pharma Licenses Rights to Lyme Disease Antibody

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 22h

Tonix Pharmaceuticals announces in-licensing of worldwide rights to TNX-4800

Tonix Pharmaceuticals (TNXP) announced the in-licensing of worldwide rights to TNX-4800, which is a long-acting human monoclonal antibody that targets the outer...

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.